Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Surveillance of resected metastatic colorectal cancer utilizing circulating DNA.
Authors
Nikolas Naleid
Department of Internal Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH
Nikolas Naleid , Kevin Zablonski , Hanna Kakish , Melissa Amy Lumish , David L Bajor , J. Eva Selfridge , Madison Conces , AMR MOHAMED , Sakti Chakrabarti , Amit Mahipal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 214)
DOI
10.1200/JCO.2024.42.3_suppl.214
Abstract #
214
Poster Bd #
N2
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Cost-effectiveness of surveillance after curative resection (CR) of metastatic colorectal cancer (CRC).
First Author: Richard M. Lee-Ying
Poster
2023 ASCO Annual Meeting
Longitudinal circulating tumor DNA monitoring for detection of molecular residual disease in patients with surgically resected stage II/III melanoma.
First Author: Revathi Kollipara
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Effect of dynamic circulating tumor DNA minimal residual disease detection on recurrence surveillance and second resection rate after curative intent resection of colorectal liver metastasis: A prospective cohort study.
First Author: Yaqi Li
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Tumor-informed patient-specific MRD monitoring analysis in colorectal cancer.
First Author: Gong Chen